Journal: Cancers
Article Title: Increased EGFR/HER2 Pathway Activation Contributes to Skin Tumorigenesis in Tpl2 − /− Mice
doi: 10.3390/cancers17203362
Figure Lengend Snippet: ErbB Receptor Upregulation in Tpl2 −/− Keratinocytes and Compensatory Response to Inhibitor Treatment. ( A ) Real-time PCR analysis of EGFR, HER2, and HER3 expression in primary keratinocytes from Tpl2 +/+ and Tpl2 −/− keratinocytes. Error bars represent SD. ( B ) Western analyses for p-EGFR, EGFR, HER2 and HER3. Tpl2 +/+ and Tpl2 −/− keratinocytes were cultured in low calcium growth media and upon 90% confluency treated with vehicle-control, 1 μM Lapatinib or 1 μM Gefitinib for 15 min (for phosphorylated protein) or 24 h (for assessing total protein) prior to isolation. NIH Image J was used for densitometry and bands were normalized to beta-actin, which served as a houskeeping gene. Densitometry changes in normalized protein (% of Tpl2 +/+ control) are displayed below each blot. Original western blots are presented in .
Article Snippet: Keratinocytes were grown at 37 °C and 5% CO 2 in keratinocyte growth media (Promocell; Heidelberg, Germany) containing hormone supplements, Penicillin-Streptomycin (10,000 U/mL) and low (0.06 mM) calcium.
Techniques: Real-time Polymerase Chain Reaction, Expressing, Western Blot, Cell Culture, Control, Isolation